Hello, future Billionaire!
The Rise and Fall of Prominent Players in Bangladesh's Capital Market
The capital market in Bangladesh, which is centered around the Dhaka Stock Exchange (DSE), has witnessed significant fluctuations, marked by the rise and fall of various prominent companies. This blog explores the historical performance of critical stocks and the factors influencing their trajectories.
Omar Farhan Fuad
5/25/20242 min read


The capital market of Bangladesh, primarily represented by the Dhaka Stock Exchange (DSE), has experienced significant fluctuations over the years. Here's an overview of the rise and fall of some of the most notable companies listed on the DSE:
Grameenphone (GP)
Grameenphone, the largest telecom operator in Bangladesh, has been a significant player in the stock market. Despite its strong market presence, Grameenphone's stock has seen volatility. In recent years, its stock price has declined by around 21.5% over the past year, reflecting broader market trends and company-specific challenges (Simply Wall St.).
Square Pharmaceuticals (SQURPHARMA)
Square Pharmaceuticals, a leading pharmaceutical company, has maintained relative stability compared to other sectors. However, its stock price still decreased by 1.9% in the past year. The company's strong fundamentals have helped it weather market downturns better than many others (Simply Wall St.).
British American Tobacco Bangladesh (BATBC)
BATBC, another major player, has experienced a sharp decline in its stock price, falling by 37.3% over the past year. This significant drop reflects sectoral challenges and broader market issues impacting investor sentiment (Simply Wall St.).
Walton Hi-Tech Industries (WALTONHIL)
Walton, a leading consumer durables manufacturer, saw its stock price fall by 48.7% over the past year. This substantial decline highlights the volatility and investor concerns within the consumer durables sector in Bangladesh (Simply Wall St.).
Robi Axiata Limited (ROBI)
Robi, the second-largest telecom operator in Bangladesh, has also faced challenges, with its stock price decreasing by 26.7% over the last year. This reflects the telecom sector's competitive pressures and regulatory challenges (Simply Wall St.).
Beximco Pharmaceuticals (BXPHARMA)
Beximco Pharmaceuticals has also seen its stock price decline, albeit less severely than other sectors. The company remains a significant player in the pharmaceutical industry, known for its robust growth and market presence (Simply Wall St.).
Market Trends and Regulatory Impacts
The DSE's overall performance has been influenced by various factors, including regulatory changes, economic conditions, and investor sentiment. In 2022, the DSE's broad market index, DSEX, fell by 8.1%, while the daily average turnover declined by 35%. The regulator's introduction of floor prices helped mitigate further declines but also led to a lack of market liquidity and investor confidence (The Daily Star).
Foreign Portfolio Investors (FPIs) have also reduced their involvement in Bangladesh's stock market, dropping to a 10-year low in 2022. This decline in foreign investment is attributed to frequent policy changes and economic uncertainties, making the market less attractive to international investors (The Daily Star).
Conclusion
The performance of individual stocks in Bangladesh's capital market has varied widely, with significant declines seen in critical sectors such as telecom, consumer durables, and pharmaceuticals. Regulatory measures and economic conditions have played crucial roles in shaping market trends. For investors, understanding these dynamics and keeping abreast of market developments is essential for making informed investment decisions.